CrushSCI.com
126.2平均天数
127中位天数
91最短天数
148最长天数
4,7452025发文量

Paper Review Records

全部论文审稿周期

5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

127 天

Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition

作者
Erik Moedt; Akihiko Koshino; Niels Jongs; Wenjun Ju; Viji Nair; Matthias Kretzler; Michael K. Hansen; Clare G. Arnott; David C. Wheeler; Peter Rossing; Steven G. Coca; Ann Hammarstedt; Peter J. Greasley; Petter Bjornstad; Stephan J.L. Bakker; Hiddo J.L. Heerspink展开收起
作者单位
1. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 2. Department of Nephrology and Rheumatology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan; 3. Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; 4. Janssen Research and Development, LLC, Spring House, Pennsylvania; 5. The George Institute for Global Health, Sydney, New South Wales, Australia; 6. Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; 7. Department of Renal Medicine, University College London, London, United Kingdom; 8. Steno Diabetes Center Copenhagen, Herlev, Denmark; 9. Icahn School of Medicine at Mount Sinai, New York, New York; 10. Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; 11. Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; 12. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; 13. Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands展开收起
官方全文证据 DOI 网页
91 天

B-Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor-T–Cell Therapy for Relapsed or Refractory AL Amyloidosis

作者
Xianghua Huang; Xiaomei Wu; Wencui Chen; Wenshi Wang; Weiwei Xu; Jinzhou Guo; Jinghua Zhao; Xiaodong Xu; Chris Wang; Aidong Shan; Jiawei Xu; Zhihong Liu展开收起
作者单位
1. National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; 2. Shanghai Fosun Kairos Biotechnology Co., Ltd., Shanghai, China展开收起
官方全文证据 DOI 网页
148 天

Kidney Function and Blood and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Related Dementias

作者
Yuwei Lin; Zaixin Zhao; Nanbo Zhu; Sara Garcia Ptacek; Juan-Jesus Carrero; Annette Bruchfeld; Maria Eriksdotter; Michelle M. Mielke; Nele Brusselaers; Hong Xu展开收起
作者单位
1. Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; 2. Institute of Advanced Clinical Medicine, Peking University, Beijing, China; 3. Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden; 4. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 5. Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden; 6. Department of Nephrology and Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 7. Department of Renal Medicine, Karolinska University Hospital, CLINTEC Karolinska Institutet, Stockholm, Sweden; 8. Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 9. Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; 10. Department of Family Medicine and Population Health, Global Health Institute, University of Antwerp, Antwerp, Belgium; 11. Department of Public Health and Primary Care, Ghent University, Ghent, Belgium展开收起
官方全文证据 DOI 网页
120 天

Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance Hemodialysis

作者
Benjamin Lidgard; Andrew N. Hoofnagle; Leila R. Zelnick; Ian H. de Boer; Paul Jensen; Amanda M. Fretts; David S. Siscovick; Jason G. Umans; Nisha Bansal; Rozenn N. Lemaitre展开收起
作者单位
1. Department of Medicine, University of Washington, Seattle, Washington; 2. New York Academy of Medicine, New York, New York; 3. Department of Medicine, Georgetown University, Washington, DC展开收起
官方全文证据 DOI 网页
145 天

Inhibition of IL-33 in Diabetic Kidney Disease

作者
Alexis Hofherr; Kaisa Mäki-Petäjä; Viknesh Selvarajah; Daniel Grice; Stefano Bartesaghi; Eulalia Jimenez; Roberto Pecoits-Filho; Hiddo J.L. Heerspink展开收起
作者单位
1. Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; 2. Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom; 3. Biometrics, Cardiovascular, Renal and Metabolism, Data Science and Artificial Intelligence, R&D, AstraZeneca, Gaithersburg, Maryland; 4. Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; 5. Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain; 6. Arbor Research Collaborative for Health, Ann Arbor, Michigan; 7. School of Medicine, Pontifical Catholic University of Parana, Curitiba, Brazil; 8. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 9. The George Institute for Global Health, University of New South Wales Sydney, Barangaroo, New South Wales, Australia展开收起
官方全文证据 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。